Abstract
Background:
The association between lung cancer and COPD has not been investigated in the primary care setting.
Method:
We determined the recent trends of lung cancer in COPD patients in the UK during the period 1991–2004, by investigating the population aged 45 and over in the General Practice Research Database.
Results:
The annual-incidence rates of lung cancer per 10,000 person-years were at least four-fold higher in patients with prior COPD (increasing from 45 to 64 in men; 29 to 48 in women) compared with the general population (from 10 to 15 in men; 5 to 10 in women). These lung cancer trends had significant annual increases that were similar in men (5%) and in women (5.5%) with prior COPD; in contrast, the annual increases of lung cancer incidence rates in the general population differed by gender, being 4% in men but double in women (8%). The three-year survival for lung cancer patients among those with prior COPD was almost half that of the general population (15% versus 26%; p<0.01) and the highest mortality was observed in men aged 45–64 (83.79 per 100 person-years; 95% CI: 69.66–97.92).
Conclusion:
These results support the association of COPD and lung cancer observed in other settings.
Similar content being viewed by others
Article PDF
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
Victor A Kiri and Joan B Soriano are former employees of GlaxoSmithKline R&D. George T Visick is currently employed by GlaxoSmithKline R&D. Leonardo M Fabbri has served as consultant to GlaxoSmithKline, Altana Pharma, AstraZeneca, Boehringer Ingelheim, Chiesi Farmaceutici, Merck Sharp & Dohme, Novartis, Roche and Pfizer. There is no other conflict of interest in this study.
Rights and permissions
About this article
Cite this article
Kiri, V., Soriano, J., Visick, G. et al. Recent trends in lung cancer and its association with COPD: an analysis using the UK GP Research Database. Prim Care Respir J 19, 57–61 (2010). https://doi.org/10.4104/pcrj.2009.00048
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.4104/pcrj.2009.00048
This article is cited by
-
Mycobacterium tuberculosis antigens repress Th1 immune response suppression and promotes lung cancer metastasis through PD-1/PDl-1 signaling pathway
Cell Death & Disease (2019)
-
Recognising Lung Cancer in Primary Care
Advances in Therapy (2019)
-
Comorbidities according to airflow limitation severity: data from comprehensive health examination in Japan
Environmental Health and Preventive Medicine (2017)
-
RNA-sequencing studies identify genes differentially regulated during inflammation-driven lung tumorigenesis and targeted by chemopreventive agents
Inflammation Research (2015)
-
Factors affecting mortality following emergency admission for chronic obstructive pulmonary disease
BMC Pulmonary Medicine (2014)